In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.

, , , , , , , , , , , , , , , , ,
M.P. Peppelenbosch (Maikel)
Erasmus University Rotterdam
hdl.handle.net/1765/135609

Ge, Z. (2021, June). Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy. Retrieved from http://hdl.handle.net/1765/135609